- Home
- QCOM vs GILD Comparison
QCOM vs GILD Comparison
Compare QCOM & GILD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QCOM
- GILD
- Stock Information
- Founded
- QCOM 1985
- GILD 1987
- Country
- QCOM United States
- GILD United States
- Employees
- QCOM N/A
- GILD N/A
- Industry
- QCOM Radio And Television Broadcasting And Communications Equipment
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- QCOM Technology
- GILD Health Care
- Exchange
- QCOM Nasdaq
- GILD Nasdaq
- Market Cap
- QCOM 169.0B
- GILD 139.6B
- IPO Year
- QCOM 1991
- GILD 1992
- Fundamental
- Price
- QCOM $165.36
- GILD $115.85
- Analyst Decision
- QCOM Buy
- GILD Buy
- Analyst Count
- QCOM 22
- GILD 23
- Target Price
- QCOM $183.10
- GILD $116.36
- AVG Volume (30 Days)
- QCOM 7.4M
- GILD 7.7M
- Earning Date
- QCOM 11-05-2025
- GILD 11-05-2025
- Dividend Yield
- QCOM 2.15%
- GILD 2.71%
- EPS Growth
- QCOM 34.21
- GILD 496.80
- EPS
- QCOM 10.36
- GILD 5.01
- Revenue
- QCOM $43,257,000,000.00
- GILD $28,863,000,000.00
- Revenue This Year
- QCOM $14.21
- GILD $2.07
- Revenue Next Year
- QCOM $1.80
- GILD $3.95
- P/E Ratio
- QCOM $15.96
- GILD $23.30
- Revenue Growth
- QCOM 15.82
- GILD 3.81
- 52 Week Low
- QCOM $120.80
- GILD $84.17
- 52 Week High
- QCOM $182.10
- GILD $121.83
- Technical
- Relative Strength Index (RSI)
- QCOM 51.92
- GILD 56.56
- Support Level
- QCOM $164.60
- GILD $108.46
- Resistance Level
- QCOM $171.75
- GILD $117.00
- Average True Range (ATR)
- QCOM 3.56
- GILD 3.05
- MACD
- QCOM -0.48
- GILD 0.25
- Stochastic Oscillator
- QCOM 9.09
- GILD 82.44
About QCOM QUALCOMM Incorporated
Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G, 4G, and 5G networks. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones, as well as chips into automotive and Internet of Things markets.
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).